Beijing, China

Yuxiao Du

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Beckman Coulter, Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yuxiao Du. Retrieved from https://idiyas.com/inventor/yuxiao-du

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank


Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yuxiao Du and a Hematological Approach to Viral Infection

Introduction

Yuxiao Du is an inventor associated with Beijing, China, and Beckman Coulter, Inc. Her patent work addresses the use of blood-cell volume biomarkers to support early detection of SARS-CoV-2 infection.

Latest Patents

Du is named on 1 patent: “Hematological Parameter for Viral Infection.” The disclosure describes automated volume biomarkers, including the lymph index and monocyte distribution width (MDW), for identifying possible viral infection. It also covers methods, devices, and computer-executable programs for using these biomarkers in the early diagnosis of SARS-CoV-2 infection.

The patent describes how these parameters may help healthcare workers in outpatient departments and fever clinics rapidly identify people who might be infected and inform triage decisions.

Career Highlights

Du’s listed patent connects hematological measurements with practical tools for early infection assessment. The disclosed approach focuses on automated biomarkers that could provide useful information during initial clinical evaluation.

Collaborations

The patent information associates Du with Beckman Coulter, Inc. The disclosed work concerns hematological parameters and automated volume biomarkers for supporting early identification of possible SARS-CoV-2 infection.

Conclusion

Yuxiao Du’s patent highlights the potential role of automated blood-cell volume biomarkers in early viral infection assessment and clinical triage.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…